Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Pronase independent flow cytometry crossmatching of rituximab treated patients.

Alheim M, Wennberg L, Wikström AC.

Hum Immunol. 2018 Feb;79(2):132-135. doi: 10.1016/j.humimm.2017.11.006. Epub 2017 Nov 20.

PMID:
29157993
2.

De Novo Donor-Specific HLA Antibody Formation in Two Patients With Crigler-Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning.

Jorns C, Nowak G, Nemeth A, Zemack H, Mörk LM, Johansson H, Gramignoli R, Watanabe M, Karadagi A, Alheim M, Hauzenberger D, van Dijk R, Bosma PJ, Ebbesen F, Szakos A, Fischler B, Strom S, Ellis E, Ericzon BG.

Am J Transplant. 2016 Mar;16(3):1021-30. doi: 10.1111/ajt.13487. Epub 2015 Nov 2.

3.

Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.

Alheim M, Paul PK, Hauzenberger DM, Wikström AC.

Hum Immunol. 2015 Nov;76(11):849-57. doi: 10.1016/j.humimm.2015.09.047. Epub 2015 Sep 30.

PMID:
26429307
4.

Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients.

Kaipe H, Carlson LM, Erkers T, Nava S, Molldén P, Gustafsson B, Qian H, Li X, Hashimoto T, Sadeghi B, Alheim M, Ringdén O.

Stem Cells Dev. 2015 Jun 15;24(12):1471-82. doi: 10.1089/scd.2014.0568. Epub 2015 Mar 13.

5.

Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination.

Ahlén G, Holmström F, Gibbs A, Alheim M, Frelin L.

Gene Ther. 2014 Aug;21(8):739-50. doi: 10.1038/gt.2014.48. Epub 2014 May 29.

6.

Flow cytometry-based cytotoxicity and antibody binding assay.

Alheim M.

Curr Protoc Cytom. 2013 Oct 9;66:6.34.1-6.34.11. doi: 10.1002/0471142956.cy0634s66.

PMID:
24510725
7.

The outcome of the endothelial precursor cell crossmatch test in lymphocyte crossmatch positive and negative patients evaluated for living donor kidney transplantation.

Alheim M, AlMahri A, Nilsson J, Tydén G, Holgersson J.

Hum Immunol. 2013 Nov;74(11):1437-44. doi: 10.1016/j.humimm.2013.06.005. Epub 2013 Jun 15.

PMID:
23777925
8.

Evaluation of a new flow cytometry crossmatch procedure for simultaneous detection of cytotoxicity and antibody binding.

Alheim M, Paul PK, Hauzenberger DM, Wikström AC.

Tissue Antigens. 2013 Aug;82(2):125-30. doi: 10.1111/tan.12151. Epub 2013 Jun 17.

PMID:
23772862
9.

Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.

AlMahri A, Holgersson J, Alheim M.

Tissue Antigens. 2012 Nov;80(5):404-15. doi: 10.1111/j.1399-0039.2012.01954.x. Epub 2012 Aug 30.

PMID:
22931381
10.

A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells.

Alheim M, Johansson SM, Hauzenberger D, Grufman P, Holgersson J.

Tissue Antigens. 2010 Mar;75(3):269-77. doi: 10.1111/j.1399-0039.2009.01439.x. Epub 2010 Jan 12.

PMID:
20070600
11.

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.

Frelin L, Brenndörfer ED, Ahlén G, Weiland M, Hultgren C, Alheim M, Glaumann H, Rozell B, Milich DR, Bode JG, Sällberg M.

Gut. 2006 Oct;55(10):1475-83. Epub 2006 Mar 9.

12.

Relation between viral fitness and immune escape within the hepatitis C virus protease.

Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.

Gut. 2006 Feb;55(2):266-74. Epub 2005 Aug 16.

13.

Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.

Frelin L, Ahlén G, Alheim M, Weiland O, Barnfield C, Liljeström P, Sällberg M.

Gene Ther. 2004 Mar;11(6):522-33.

PMID:
14999224
14.

Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo.

Frelin L, Alheim M, Chen A, Söderholm J, Rozell B, Barnfield C, Liljeström P, Sällberg M.

Gene Ther. 2003 Apr;10(8):686-99.

PMID:
12692597
15.

Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent.

Lazdina U, Alheim M, Nyström J, Hultgren C, Borisova G, Sominskaya I, Pumpens P, Peterson DL, Milich DR, Sällberg M.

J Gen Virol. 2003 Jan;84(Pt 1):139-46.

PMID:
12533710
16.

Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells.

Yu S, Zhu Y, Chen Z, Alheim M, Ljungberg A, Zhu J.

J Neurosci Res. 2002 Mar 15;67(6):823-8.

PMID:
11891797
18.

Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.

Lazdina U, Cao T, Steinbergs J, Alheim M, Pumpens P, Peterson DL, Milich DR, Leroux-Roels G, Sällberg M.

J Virol. 2001 Jul;75(14):6367-74.

Supplemental Content

Loading ...
Support Center